DIAGNOSTIC AND THERAPEUTIC USE OF RAS-GTPASE-ACTIVATING PROTEIN SH3-DOMAIN-BINDING PROTEIN 2 (G3BP2) FOR NEURODEGENERATIVE DISEASES

Details for Australian Patent Application No. 2003278497 (hide)

Owner EVOTEC NEUROSCIENCES GMBH

Inventors VON DER KAMMER, Heinz; POHLNER, Johannes

Pub. Number AU-A-2003278497

PCT Number PCT/EP2003/0065

PCT Pub. Number WO2004/001422

Priority 60/389,927 20.06.02 US; 02013692.5 20.06.02 EP

Filing date 20 June 2003

Wipo publication date 6 January 2004

International Classifications

G01N 033/68 Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

C07K 014/47 Peptides having more than 20 amino acids

C12N 015/00 Mutation or genetic engineering

A01K 067/027 Rearing or breeding animals, not otherwise provided for - New breeds of vertebrates

Event Publications

26 February 2004 Complete Application Filed

  Priority application(s): 60/389,927 20.06.02 US; 02013692.5 20.06.02 EP

4 March 2004 Application Open to Public Inspection

  Published as AU-A-2003278497

14 July 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003278498-BROADCAST HAND-OVER IN A WIRELESS NETWORK

2003278496-USE OF RMLT AS A MARKER ANTIGEN FOR VACCINES AND AS A SYNERGISTIC ADJUVANT WITH AMPHIGEN